AI breakthrough could spare thousands from unnecessary surgery for uterine fibroids
NCT ID NCT07269535
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This study will test an artificial intelligence (AI) model that uses MRI scans to tell the difference between benign uterine fibroids and a rare but aggressive cancer called uterine sarcoma. Researchers will enroll 500 women who are scheduled for surgery or long-term follow-up. The goal is to see if the AI tool can accurately identify high-risk cases, potentially reducing unnecessary surgeries and improving early detection of cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AI (ARTIFICIAL INTELLIGENCE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.